IL17A and renal fibrosis: In lupus nephritis, IL-17A is implicated in multiple stages of disease progression, including modifying the structure and function of specialized renal cells, fostering an inflammatory environment, and contributing to recurrent tissue damage and ineffective repair processes, ultimately leading to renal fibrosis and functional decline.